• Skip to main content
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Psychiatric Research Institute
  • UAMS Health
  • Jobs
  • Giving
  • Clinical Care
    • Outpatient Care
      • AR ConnectNow
      • Center for Addiction Services and Treatment
        • Improving Access To Treatment For Opioid Use Disorder
        • MATRIARC
          • Project ECHO
        • Medication and Counseling Treatment
        • Medications To Treat Opioid Use Disorders
        • Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
        • Suboxone Treatment Program
        • Subutex Treatment Program
        • What is Buprenorphine?
        • What Is Methadone?
        • What Is Naltrexone?
        • What Is Vivitrol?
        • Drugs and Addiction
        • New Hybrid Care Program
        • Opioid Use Disorder
      • Child Study Center
        • Dialectical Behavior Therapy
        • Family Resources
          • Handouts for Parents
          • Books
          • Videos
        • Meet the Team – Child Study Center
        • Treatment and Services
      • Psychiatry Clinic in Fayetteville
        • Meet the Team
      • Six Bridges Clinic
      • STRIVE
      • Walker Family Clinic
        • Mental Health Resources
      • Women’s Mental Health Program
        • Peer Support Specialist Services
        • Reproductive Psychiatry Fellowship
        • Substance Use Treatment
        • WMHP Research
        • Women’s Inpatient Unit – 5 North
        • Women’s Mental Health Clinic
        • Women’s Mental Health Program – Fayetteville Branch
      • Odyssey Clinic
        • Northwest Arkansas Schizophrenia Conference 2025 Media
        • Schizophrenia Conference 2024 Media
      • Neuropsychology
    • Inpatient Units
      • Child Diagnostic Unit
        • Child Diagnostic Unit Videos
      • Women’s Inpatient Unit – 5 North
    • Interventional Psychiatry
      • Electroconvulsive Therapy
      • Esketamine
      • Ketamine Infusions
      • Patient-Visitor Guide To Little Rock
      • SAINT® Neuromodulation System
  • News
  • PRI Journal
  • Education
  • Research
    • Center for Addiction Research
      • Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
      • What is Vivitrol?
      • Faculty
        • Alison Oliveto, Ph.D
        • Merideth Addicott, Ph.D.
        • Michael Mancino, M.D.
        • Nihit Kumar, M.D.
    • Center for Health Services Research
      • Behavioral Health QUERI
      • Health Services Research and Development Service
      • Rural Outreach Program
        • Rural Outreach Program Team
      • South Central (VISN 16) Mental Illness Research, Education and Clinical Center
      • Center for Health Services Research Faculty and Staff
        • Alexis S. Childs, Psy.D.
        • Brandon J. Griffin, Ph.D.
        • Christopher Long, Ph.D.
        • Corey Hayes, Pharm.D., Ph.D., MPH
        • Eva Woodward, Ph.D.
        • Jacob Painter, Pharm.D, Ph.D.
        • Leah Tobey, PT, DPT, MBA
        • Marcela Weber, Ph.D.
        • Mary J. Bollinger, MPH, Ph.D.
        • Meghan Breckling, Pharm.D., BCACP
        • Melissa J. Zielinski, Ph.D.
        • Michael Cucciare, Ph.D.
        • Prasad R. Padala, M.D., M.S., FACHE
        • Rajinder “Sonia” Singh, Ph.D.
        • Rebecca Raciborski, Ph.D.
        • Ronald G. Thompson, Jr., Ph.D., LCSW
        • Sara J. Landes, Ph.D.
        • Traci Abraham, Ph.D.
        • Angie Waliski, Ph.D.
        • Geoffrey M. Curran, Ph.D.
        • Greer Sullivan, M.D., M.S.P.H.
        • Jeffrey M. Pyne, M.D.
        • Joy Reeves Pemberton, Ph.D.
        • Karen Drummond, Ph.D.
        • Kristen M. Viverito, Psy.D.
        • Puru Thapa, M.D., M.P.H.
        • Richard R. Owen, M.D.
        • Teresa Hudson, Pharm.D., Ph.D.
        • Teresa L. Kramer, Ph.D.
      • Postdoctoral Fellowship
        • CeMHOR/HSR&D
        • MIRECC
    • Health and the Legal System (HEALS) Lab
      • Projects in the Health and the Legal System (HEALS) Lab
      • Publications and Media
      • About the HEALS Lab
    • Neurodevelopmental Risk and Resilience Program
    • Research Trials
    • Trauma REsilience & Community Collaboration (TRECC)
      • About TRECC
      • Get Involved
      • Research
        • Current Projects
        • Media
        • Selected Research Publications
      • Resources
        • Measures
        • Tools And Tool Kits
    • Helen L. Porter and James T. Dyke Brain Imaging Research Center
  • Patients and Visitors
    • Art of the Psychiatric Research Institute
    • Mental Health Resources
    • Mission And Vision Statements
    • Social Media
    • Map and Directions
    • Job Openings
    • Faculty and Staff
    • Giving
  1. University of Arkansas for Medical Sciences
  2. Psychiatric Research Institute
  3. Research
  4. Neurodevelopmental Risk and Resilience Program

Neurodevelopmental Risk and Resilience Program

Ashley Acheson, Ph.D., professor and vice chair for research for the UAMS Department of Psychiatry in the College of Medicine, is a behavioral neuroscientist who joined the UAMS in October 2016.

Acheson attended the University of Wisconsin-Whitewater for his undergraduate education, receiving bachelor’s degree in psychology with a minor in biology. He completed his doctoral studies at the University at Buffalo – The State University of New York (SUNY) where he completed his Ph.D. in behavioral neuroscience. Later, he completed his postdoctoral training at the University of Chicago and the University of Texas Health Science Center at San Antonio (UTHSCSA), supported by T32 fellowships from the National Institute on Drug Abuse and the National Institute of Mental Health..

In 2007, he joined the faculty at the UTSCSA Department of Psychiatry, later becoming an associate professor. At UTSCSA, he completed a KL2 Research Career Development Scholar Program and developed a research program examining behavioral and neurobiological risk factors for alcohol and other drug addictions that was funded by over $5 million in NIH grants. 

Since joining UAMS, Acheson has been awarded over $13 million in NIH grants. His ongoing research includes the Family Health Patterns Project, a long-running study aimed at identifying behavioral and biological factors underlying risk for addictions.  He also is a principal investigator on the HEALthy Brain and Child Development (HBCD) Study, the largest ever study of child brain development. The HBCD Study will offer unprecedented opportunities to study how early life influences promote risk and resilience for addictions and other psychopathology. He hopes that his work will lead to improved addiction prevention and early intervention strategies.

Publications

https://scholar.google.com/citations?user=mjf-UHEAAAAJ&hl=en

Research Funding

https://reporter.nih.gov/search/iXBJcJi1tU6EJngdsgDtNg/projects

Current Projects

Family Health Patterns (FHP) Project

The FHP Project is a long-running study aimed at characterizing behavioral and biological factors associated with family histories of alcoholism and early-life adversity exposure.  Activities during the current funding period are focused on examining how family histories of alcoholism and early-life adversity affect immune regulation and frontal white matter myelination and health. Ultimately this work hopes to better inform how family history and early life experience influence risk for problem alcohol and other drug use.

We are currently seeking healthy young adults ages 18-25 to participate in this study.  If interested, please go to https://base.uams.edu/redcap/surveys/?s=4K3NRPKYEE.

HEALthy Brain and Child Development (HBCD) Study

The HBCD study is the largest ever study of child brain development. It will follow 7,500 children from the prenatal period to at least ages 9-10.  The study will investigate how things like prenatal opioid and other drug exposure, nutrition and early life environment influences influence risk for early substance use, mental disorders, and other behavioral and developmental problems. It will also identify resilience factors that may mitigate some of these adverse outcomes.  For more information please see https://hbcdstudy.org.

Locally, we will be recruiting 300 children and their parent to participant.  Information on how to participate will be available soon.

Psychiatric Research Institute LogoPsychiatric Research InstitutePsychiatric Research Institute
Mailing Address: 4224 Shuffield Drive, Little Rock, AR 72205
Phone: (501) 526-8100
  • Facebook
  • X
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement
  • Legal Notices

© 2025 University of Arkansas for Medical Sciences